D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 144 Citations 86,579 684 World Ranking 559 National Ranking 337

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Heart failure
  • Cardiology

Mihai Gheorghiade mainly focuses on Heart failure, Internal medicine, Cardiology, Heart disease and Intensive care medicine. Mihai Gheorghiade works on Heart failure which deals in particular with Ejection fraction. In his study, Severity of illness is strongly linked to Surgery, which falls under the umbrella field of Internal medicine.

His work on Randomization expands to the thematically related Cardiology. His work carried out in the field of Heart disease brings together such families of science as Dobutamine, Mortality rate, Circulatory system, Disease and Etiology. His research integrates issues of Guideline, Epidemiology, MEDLINE and Emergency medicine in his study of Intensive care medicine.

His most cited work include:

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (3995 citations)
  • The effect of digoxin on mortality and morbidity in patients with heart failure (1936 citations)
  • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (1542 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction. In general Heart failure, his work in Tolvaptan is often linked to In patient linking many areas of study. His biological study spans a wide range of topics, including Placebo and Surgery.

The Cardiology study combines topics in areas such as Prospective cohort study and Blood pressure. His Intensive care medicine study incorporates themes from Epidemiology, MEDLINE, Drug development, Emergency medicine and Disease. His Ejection fraction study frequently draws parallels with other fields, such as Pulmonary wedge pressure.

He most often published in these fields:

  • Heart failure (83.97%)
  • Internal medicine (70.03%)
  • Cardiology (60.39%)

What were the highlights of his more recent work (between 2013-2021)?

  • Heart failure (83.97%)
  • Internal medicine (70.03%)
  • Cardiology (60.39%)

In recent papers he was focusing on the following fields of study:

His main research concerns Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction. His Heart failure study frequently involves adjacent topics like Clinical trial. His research investigates the connection between Internal medicine and topics such as Placebo that intersect with problems in Aliskiren.

His Cardiology research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Tolerability, Interquartile range and Clinical endpoint. His Intensive care medicine study also includes

  • Drug development which connect with Cardiovascular agent,
  • Diuretic and related Hemoconcentration. His Ejection fraction study incorporates themes from Prospective cohort study, Surgery, Quality of life, Blood pressure and Myocardial infarction.

Between 2013 and 2021, his most popular works were:

  • The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. (1015 citations)
  • Phenomapping for novel classification of heart failure with preserved ejection fraction. (457 citations)
  • Expert consensus document: Mitochondrial function as a therapeutic target in heart failure (251 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Heart failure
  • Disease

Mihai Gheorghiade spends much of his time researching Heart failure, Internal medicine, Cardiology, Ejection fraction and Intensive care medicine. His Heart failure research incorporates themes from Diabetes mellitus, Interquartile range and Clinical trial. His biological study deals with issues like Placebo, which deal with fields such as Randomized controlled trial.

His Cardiology research integrates issues from Disease progression, Tolerability, Proportional hazards model and Cohort study. His Ejection fraction research incorporates elements of Coronary artery disease, Surgery, Myocardial infarction and Atrial fibrillation. He combines subjects such as Endocrinology, Kidney disease, Cardiovascular agent and Comorbidity with his study of Intensive care medicine.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel.
The Lancet (1999)

3995 Citations

The effect of digoxin on mortality and morbidity in patients with heart failure

G Perry;E Brown;R Thornton;T Shiva.
The New England Journal of Medicine (1997)

3238 Citations

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008

Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray.
European Journal of Heart Failure (2008)

2484 Citations

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness

James A. Hill;Daniel F. Pauly;Debra R. Olitsky;Stuart Russell.
JAMA (2005)

1625 Citations

Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial

Marvin A. Konstam;Mihai Gheorghiade;John C. Burnett;Liliana Grinfeld.
JAMA (2007)

1594 Citations

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

Andrew P. Ambrosy;Gregg C. Fonarow;Javed Butler;Ovidiu Chioncel.
Journal of the American College of Cardiology (2014)

1490 Citations

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.

Robert W. Schrier;Robert W. Schrier;Peter Gross;Mihai Gheorghiade;Tomas Berl.
The New England Journal of Medicine (2006)

1308 Citations

Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.

Gregg C. Fonarow;Wendy Gattis Stough;William T. Abraham;Nancy M. Albert.
Journal of the American College of Cardiology (2007)

1229 Citations

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Michael S. Cuffe;Robert M. Califf;Kirkwood F. Adams;Raymond Benza.
JAMA (2002)

1225 Citations

Chronic Heart Failure in the United States A Manifestation of Coronary Artery Disease

Mihai Gheorghiade;Robert O. Bonow.
Circulation (1998)

1114 Citations

Best Scientists Citing Mihai Gheorghiade

Gregg C. Fonarow

Gregg C. Fonarow

University of California, Los Angeles

Publications: 387

John J.V. McMurray

John J.V. McMurray

University of Glasgow

Publications: 340

John G.F. Cleland

John G.F. Cleland

National Institutes of Health

Publications: 331

Marco Metra

Marco Metra

University of Brescia

Publications: 312

Christopher M. O'Connor

Christopher M. O'Connor

Duke University

Publications: 281

Adrian F. Hernandez

Adrian F. Hernandez

Duke University

Publications: 277

Javed Butler

Javed Butler

University of Mississippi

Publications: 255

Gerasimos Filippatos

Gerasimos Filippatos

National and Kapodistrian University of Athens

Publications: 250

Piotr Ponikowski

Piotr Ponikowski

Wrocław Medical University

Publications: 238

Ali Ahmed

Ali Ahmed

Georgetown University

Publications: 236

Adriaan A. Voors

Adriaan A. Voors

University Medical Center Groningen

Publications: 232

Dirk J. van Veldhuisen

Dirk J. van Veldhuisen

University Medical Center Groningen

Publications: 213

Alexandre Mebazaa

Alexandre Mebazaa

Université Paris Cité

Publications: 206

Faiez Zannad

Faiez Zannad

University of Lorraine

Publications: 200

G. Michael Felker

G. Michael Felker

Duke University

Publications: 200

Karl Swedberg

Karl Swedberg

University of Gothenburg

Publications: 191

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.